April 30 (Reuters) - Beigene 688235.SS:
SAYS PHARMACYCLICS LITIGATION IS NOT HAVING ADVERSE EFFECT ON DEVELOPMENT, SALES OF BRUKINSA IN U.S.
SAYS PHARMACYCLICS LITIGATION IS NOT EXPECTED TO HAVE companyADVERSE EFFECT ON CO'S PRODUCTION, OPERATION
Source text
Further company coverage: 688235.SS
(Reporting by Hong Kong newsroom)
((donny.kwok@thomsonreuters.com; +852 3462 7745;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.